Affinity of drugs and small biologically active molecules to carbon nanotubes: A pharmacodynamics and nanotoxicity factor?

Molecular Pharmaceutics

Volumn 6, Issue 3, 2009, Pages 873-882

  Liu, John ^a   Yang, Liu ^b   Hopfinger, Anton J ^a,c  

^a Chem21 Group Inc   (United States)

^b UNIVERSITY OF DELAWARE   (United States)

^c UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

Carbon nanotubes; Drug binding; Molecular dynamics; Nanotoxicity; Pharmacodynamics

Indexed keywords

1,2 DIMYRISTOYL EN GLYCEROPHOSPHATIDYLETHANOLAMINE; ACETYLSALICYLIC ACID; ARGATROBAN; AZAPROPAZONE; CARBON NANOTUBE; CELECOXIB; CHLORPROMAZINE; COUMARIN; DABIGATRAN; DICLOFENAC; DIMYRISTOYLPHOSPHATIDYLGLYCEROL; DIMYRISTOYLPHOSPHATIDYLINOSITOL; HUMAN SERUM ALBUMIN; IBUPROFEN; LEUKOTRIENE; MISOPROSTOL; MONTELUKAST; PHENOBARBITAL; PHOSPHOLIPID DERIVATIVE; PROPOFOL; PROSTACYCLIN; ROFECOXIB; UNCLASSIFIED DRUG; WARFARIN; XIMELAGATRAN; ZAFIRLUKAST; ZILEUTON;

AQUEOUS SOLUTION; ARTICLE; BINDING AFFINITY; CORRELATION ANALYSIS; DRUG BINDING; DRUG RECEPTOR BINDING; DRUG STRUCTURE; LIGAND BINDING; MATHEMATICAL COMPUTING; MOLECULAR DYNAMICS; MOLECULAR MECHANICS; MOLECULAR MODEL; NANOTOXICOLOGY; PHARMACODYNAMICS; PRIORITY JOURNAL; PROTEIN STRUCTURE; SIMULATION; VALIDATION STUDY;

HUMANS; LIGANDS; MODELS, MOLECULAR; NANOTUBES, CARBON; PHARMACEUTICAL PREPARATIONS; PROTEIN BINDING; PROTEIN STRUCTURE, SECONDARY; SERUM ALBUMIN; THERMODYNAMICS;

EID: 67449085951     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp800197v     Document Type: Article

References (39)

1. Donaldson, K.; Stone, V.; Tran, C. L.; Kreyling, W.; Borm, P. J. A. Nanotoxicology. Occup. Environ. Med. 2004, 61 (9), 727-728.
2. Service, R. F. Nanotoxicology: Nanotechnology grows up. Science 2004, 304 (5678), 1732-1734. (Pubitemid 38787869)
3. Symposium abstracts. In Environ. Mol. Mutagen. 2007, 48, 524-549.
4. Fischer, H. C.; Chan, W. C. W. Nanotoxicity: the growing need for in vivo study. Curr. Opin. Biotechnol. 2007, 18 (6), 565-571.
5. Zhao, Y.; Xing, G.; Chai, Z. Nanotoxicology: Are carbon nanotubes safe? Nat. Nanotechnol. 2008, 3 (4), 191-192.
6. Ash Genaidy, W. K. Nanotechnology occupational and environmental health and safety: Education and research needs for an emerging interdisciplinary field of study. Hum. Factors Ergon. Manuf. 2006, 16 (3), 247-253.
7. Service, R. F. US nanotechnology - Health and safety research slated for sizable gains. Science 2007, 315 (5814), 926-1926
8. Lam, C. W.; James, J. T.; McCluskey, R.; Arepalli, S.; Hunter, R. L. A review of carbon nanotube toxicity and assessment of potential occupational and environmental health risks. Crit. Rev. Toxicol. 2006, 36 (3), 189-217.
9. Shvedova, A. A.; Castranova, V.; Kisin, E. R.; Schwegler-Berry, D.; Murray, A. R.; Gandelsman, V. Z.; Maynard, A.; Baron, P. Exposure to carbon nanotube material: Assessment of nanotube cytotoxicity using human keratinocyte cells. J. Toxicol. Environ. Health, Part A 2003, 66 (20), 1909-1926. (Pubitemid 37352634)
10. Hilder, T. A.; Hill, J. M. Theoretical comparison of nanotube materials for drug delivery. Micro Nano Lett., IET 2008, 3 (1), 18-24.
11. Kostarelos, K. The long and short of carbon nanotube toxicity. Nat. Biotechnol. 2008, 26 (7), 774-776. (Pubitemid 351961446)
12. Poland, C. A.; Duffin, R.; Kinloch, I.; Maynard, A.; Wallace, W. A. H.; Seaton, A.; Stone, V.; Brown, S.; MacNee, W.; Donaldson, K. Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study. Nat. Nanotechnol. 2008, 3 (7), 423-428.
13. Chakravarty, P.; Marches, R.; Zimmerman, N. S.; Swafford, A. D. E.; Bajaj, P.; Musselman, I. H.; Pantano, P.; Draper, R. K.; Vitetta, E. S. Thermal ablation of tumor cells with antibody-functionalized single-walled carbon nanotubes. Proc. Natl. Acad. Sci. U.S.A. 2008, 105 (25), 8697-8702. (Pubitemid 351987743)
14. Liu, Z.; Davis, C.; Cai, W.; He, L.; Chen, X.; Dai, H. Circulation and long-term fate of functionalized, biocompatible single-walled carbon nanotubes in mice probed by Raman spectroscopy. Proc. Natl. Acad. Sci. U.S.A. 2008, 105 (5), 1410-1415. (Pubitemid 351346531)
15. Monteiro-Riviere, N. A.; Nemanich, R. J.; Inman, A. O.; Wang, Y. Y.; Riviere, J. E. Multi-walled carbon nanotube interactions with human epidermal keratinocytes. Toxicol. Lett. 2005, 155 (3), 377-384. (Pubitemid 40093001)
16. Witzmann, F. A.; Monteiro-Riviere, N. A. Multi-walled carbon nanotube exposure alters protein expression in human keratinocytes. Nanomedicine 2006, 2 (3), 158-168. (Pubitemid 44403217)
17. Guo, L.; Bussche, A. V. D.; Buechner, M.; Yan, A.; Kane, A. B.; Hurt, R. H. Adsorption of Essential Micronutrients by Carbon Nanotubes and the Implications for Nanotoxicity Testing. Small 2008, 4 (6), 721-727. (Pubitemid 352007131)
18. Hummer, G.; Rasaiah, J. C.; Noworyta, J. P. Water conduction through the hydrophobic channel of a carbon nanotube. Nature (London) 2001, 414 (6860), 188-190. (Pubitemid 33051229)
19. Lopez, C. F.; Nielsen, S. O.; Moore, P. B.; Klein, M. L. Understanding nature's design for a nanosyringe. Proc. Natl. Acad. Sci. U.S.A. 2004, 101 (13), 4431-4434. (Pubitemid 38443360)
20. Liu, J.; Hopfinger, A. J. Identification of Possible Sources of Nanotoxicity from Carbon Nanotubes Inserted into Membrane Bilayers Using Membrane Interaction Quantitative Structure-Activity Relationship Analysis. Chem. Res. Toxicol. 2008, 21 (2), 459-466.
21. Wermuth, C. M. The Practice of Medicinal Chemistry, 2nd ed.; Academic Press: London, 2003.
22. Bhattacharya, A. A.; Curry, S.; Franks, N. P. Binding of the general anesthetics propofol and halothane to human serum albumin - High resolution crystal structures. J. Biol. Chem. 2000, 275 (49), 38731-38738. (Pubitemid 32009208)
23. Ghuman, J.; Zunszain, P. A.; Petitpas, I.; Bhattacharya, A. A.; Otagiri, M.; Curry, S. Structural basis of the drug-binding specificity of human serum albumin. J. Mol. Biol. 2005, 353 (1), 38-52. (Pubitemid 41338838)
24. Tozer, T. N.; Rowland, M. Introduction to Pharmacokinetics and Pharmacodynamics: The Quantitative Basis of Drug Therapy, 1st ed.; Lippincott Williams & Wilkins: New York, 2006.
25. Kollman, P. A.; Massova, I.; Reyes, C.; Kuhn, B.; Huo, S.; Chong, L.; Lee, M.; Lee, T.; Duan, Y.; Wang, W.; Donini, O.; Cieplak, P.; Srinivasan, J.; Case, D. A.; Cheatham, T. E. Calculating Structures and Free Energies of Complex Molecules: Combining Molecular Mechanics and Continuum Models. Acc. Chem. Res. 2000, 33 (12), 889-897. (Pubitemid 32056774)
26. Case, D. A.; Darden, T. A.; Cheatham, T. E., III;; Simmerling, C. L.; Wang, J. D.; R. E.; Luo, R.; Merz, K. M.; Pearlman, D. A.; Crowley, M.W.; R. C.; Zhang, W.;Wang, B.; Hayik, S.; Roitberg, A.; Seabra, G.; Wong, K. F.; Paesani, F.; Wu, X.; Brozell, S.; Tsui, V.; Gohlke, H.; Yang, L.; Tan, C.; Mongan, J.; Hornak, V.; Cui, G.; Beroza, P.; Mathews, D. H.; Schafmeister, C.; Ross, W. S.; Kollman, P. A. AMBER 9, 9th ed.; University of California: San Francisco, 2006.
27. Pearlman, D. A.; Case, D. A.; Caldwell, J. W.; Ross, W. S.; Cheatham, T. E.; DeBolt, S.; Ferguson, D.; Seibel, G.; Kollman, P. AMBER, a package of computer programs for applying molecular mechanics, normal mode analysis, molecular dynamics and free energy calculations to simulate the structural and energetic properties of molecules. Comput. Phys. Commun. 1995, 91 (1-3), 1-41.
28. O'Neil, M. J.; Smith, A.; Heckelman, P. E.; Budavari, S. The Merck Index, 13th ed.; Merck Publishing Group: Whitehouse Station, NJ, 2006.
29. Liu, J.; Yang, L.; Li, Y.; Pan, D.; Hopfinger, A. Prediction of plasma protein binding of drugs using Kier-Hall valence connectivity indices and 4D-fingerprint molecular similarity analyses. J. Comput.-Aided Mol. Des. 2005, 19 (8), 567-583. (Pubitemid 43150049)
30. Hauptmann, J. Pharmacokinetics of an emerging new class of anticoagulant/antithrombotic drugs - A review of small-molecule thrombin inhibitors. Eur. J. Clin. Pharm. 2002, 57 (11), 751-758. (Pubitemid 34143330)
31. Weeks, J. R. General Pharmacology of Prostacyclin, (PGX) - New prostaglandin especially active on cardiovascular system. Acta Biol. Med. Ger. 1978, 37 (5-6), 707-714. (Pubitemid 9097931)
32. Pascher, I.; Sundell, S.; Harlos, K.; Eibl, H. Conformation and packing properties of membrane lipids: the crystal structure of sodium dimyristoylphosphatidylglycerol. Biochim. Biophys. Acta, Biomembr. 1987, 896, 77-88.
33. Bradshaw, J. P.; Bushby, R. J.; Giles, C. C. D.; Saunders, M. R. Orientation of the headgroup of phosphatidylinositol in a model biomembrane as determined by neutron diffraction. Biochemistry 1999, 38 (26), 8393-8401. (Pubitemid 129515154)
34. Hauser, H.; Pascher, I.; Pearson, R. H.; Sundell, S. Preffered conformation and moelcular packing of phosphatidylethanolamine and phosphatidylcholine. Biochim. Biophys. Acta 1981, 650, 21-51.
35. Williams, D. A.; Lemke, T. L.; Foye, W. O. Foye's Principles of Medicinal Chemistry, 5th ed.; Lippincott Williams & Wilkins: New York, 2002.
36. http://www.rxlist.com/flolan-drug.htm, accessed 12/18/2008.
37. www.nature.com/nchina/2008/080409/full/nchina, accessed 12/21/2008.
38. www.naturalnews.com/024215.html, accessed 12/20/2008.
39. www.physorg.com/news114348754.html, accessed 12/20/2008.